Heart failure & cardiomyopathies

Prevalence and Prognostic Value of Different Iron Deficiency Definitions in Light Chain Cardiac Amyloidosis Patients

ESC Heart FailPublished study

Authors' conclusion

Different definitions of ID yield inconsistent results in terms of prevalence and prognosis. ID, as defined by TSAT < 20% or serum iron < 13 μmol/L, rather than the guideline definition, emerged as an independent predictor of all-cause mortality in patients with AL-CM.

Study context

Population
Patients diagnosed with light chain cardiac amyloidosis (AL-CM) at Heart Failure Center, Fuwai Hospital between September 2017 and October 2023patients included, 60 (40.3%) female, 127 (85.2%) New York Heart Association (NYHA) class III–IV, 136 (91.3%) revised Mayo 2012 stage III–IV
Participants
149 patients
Comparison
Iron deficiency (ID) vs no ID under three different ID definitions, for prevalence and association with all-cause mortality
  • ID (guideline definition)n = 63
  • ID (transferrin saturation (TSAT) < 20%)n = 61
  • ID (serum iron <13 μmol/L)n = 105
Outcome
All-cause mortality

Main finding

As reported in the abstract

Estimate (95% CI)P value
ID (TSAT < 20%)unadjusted; higher mortality with ID
HR 2.14(1.36–3.37)
P < 0.001
ID (serum iron <13 μmol/L)unadjusted; higher mortality with ID
HR 2.16(1.23–3.80)
P < 0.01
ID (guideline definition)unadjusted; association not seen
HR 1.39(0.88–2.18)
P = 0.158
ID (TSAT < 20%)adjusted for age, gender, haemoglobin, and revised 2012 Mayo staging
adjusted HR 2.49(1.54–4.05)
P < 0.001
ID (serum iron <13 μmol/L)adjusted for age, gender, haemoglobin, and revised 2012 Mayo staging
adjusted HR 2.24(1.23–4.09)
P < 0.01

Further findings

Prevalence of ID by definition

  • Prevalence of ID by definition: P < 0.0001

Iron biomarkers

Median ferritin
183.68 ng/mL (interquartile range [IQR] 95.48, 339.01)
Median TSAT
21.80% (IQR 16.34, 29.48)
Median serum iron
10.87 μmol/L (IQR 7.38, 13.71)
Correlation of serum iron with TSAT
r = 0.85, P < 0.0001

Original publication

Prevalence and Prognostic Value of Different Iron Deficiency Definitions in Light Chain Cardiac Amyloidosis Patients. ESC Heart Fail. Published 8 February 2025. doi:10.1002/ehf2.15227

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.